Trials / Completed
CompletedNCT01950312
The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
An Open-label Study of the Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- XOMA (US) LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if gevokizumab therapy may be an alternate therapy in patients with steroid resistant Autoimmune Inner Ear Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gevokizumab |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2015-10-01
- Completion
- 2015-12-01
- First posted
- 2013-09-25
- Last updated
- 2016-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01950312. Inclusion in this directory is not an endorsement.